Michelle Yanez
CIK: 0001958023
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- May 4, 2026INTI
Inhibitor Therapeutics, Inc.
Award(A)Direct50K shares- - Apr 1, 2025INTI
Inhibitor Therapeutics, Inc.
Award(A)Direct50K shares- - Dec 9, 2024MIRA
MIRA PHARMACEUTICALS, INC.
Award(A)DirectStock Options (right to buy)
150K shares- - Dec 2, 2024INTI
Inhibitor Therapeutics, Inc.
Gift(G)Direct250K shares- - Aug 27, 2024TELO
Telomir Pharmaceuticals, Inc.
Award(A)DirectIncentive Stock Options (right to buy)
200K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 |  INTI Inhibitor Therapeutics, Inc. | Award(A) | 50,000 | - | $0 | Direct |
| Apr 1, 2025 | INTI Inhibitor Therapeutics, Inc. | Award(A) | 50,000 | - | - | Direct |
| Dec 9, 2024 |  MIRA MIRA PHARMACEUTICALS, INC. | Award(A) Stock Options (right to buy) | 150,000 | - | - | Direct |
| Dec 2, 2024 | INTI Inhibitor Therapeutics, Inc. | Gift(G) | 250,000 | - | - | Direct |
| Aug 27, 2024 |  TELO Telomir Pharmaceuticals, Inc. | Award(A) Incentive Stock Options (right to buy) | 200,000 | - | - | Direct |
1-5 of 5 transactions
About Yanez Michelle
Yanez Michelle (SEC CIK 0001958023) files insider reports with the SEC as Director of Inhibitor Therapeutics, Inc. (INTI), Chief Financial Officer of MIRA PHARMACEUTICALS, INC. (MIRA) and Chief Financial Officer of Telomir Pharmaceuticals, Inc. (TELO).
Signal8 holds 5 ownership filings by Yanez Michelle (4 Form 4, 1 Form 5), filed between Sep 4, 2024 and Aug 4, 2026. Those filings report 5 transactions, from Aug 27, 2024 to May 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Yanez Michelle's filings is in TAMPA, FL.
Recent filings by Yanez Michelle
- May 4, 2026: Grant or award of INTI shares (Form 4, code A).
- Apr 1, 2025: Grant or award of INTI shares (Form 4, code A).
- Dec 9, 2024: Grant or award of MIRA derivative securities (Form 4, code A).
- Dec 2, 2024: Gift of INTI shares (Form 5, code G).
- Aug 27, 2024: Grant or award of TELO derivative securities (Form 4, code A).
Other insiders filing for Inhibitor Therapeutics, Inc. (INTI)
- Black Robe Capital LLC, 10% Owner
- OSMAN RONALD E, Director
- SEARS SAMUEL P JR, Director
- ODONNELL FRANCIS E JR, Chief Executive Officer
- Jerman Michael Allen, Director
- Vasisht Niraj, Director